Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL‐24 enhances the antitumor effect of temozolomide against melanoma

BACKGROUND: Temozolomide (TMZ) is widely used to treat melanoma; however, response rates to TMZ are low because of rapid and frequent resistance. Conditionally, replicative adenoviruses (CRAds) are an effective and promising approach. The receptor for adenovirus is coxsackie‐adenovirus receptor (CAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ming, Yang, Chunsheng, Tao, Yingkai, Tang, Jianqin, Huang, Qian, Guo, Wenwen, Feng, Shouxin, Jiang, Aijun, Xu, Xifeng, Jiang, Guan, Liu, Yanqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308089/
https://www.ncbi.nlm.nih.gov/pubmed/30406970
http://dx.doi.org/10.1002/cam4.1843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308089/
https://www.ncbi.nlm.nih.gov/pubmed/30406970
http://dx.doi.org/10.1002/cam4.1843

Ejemplares similares